全文获取类型
收费全文 | 12000篇 |
免费 | 934篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 405篇 |
妇产科学 | 121篇 |
基础医学 | 911篇 |
口腔科学 | 50篇 |
临床医学 | 3983篇 |
内科学 | 1219篇 |
皮肤病学 | 74篇 |
神经病学 | 1378篇 |
特种医学 | 140篇 |
外科学 | 773篇 |
综合类 | 776篇 |
现状与发展 | 1篇 |
一般理论 | 10篇 |
预防医学 | 2164篇 |
眼科学 | 23篇 |
药学 | 578篇 |
5篇 | |
中国医学 | 166篇 |
肿瘤学 | 181篇 |
出版年
2024年 | 21篇 |
2023年 | 331篇 |
2022年 | 455篇 |
2021年 | 636篇 |
2020年 | 595篇 |
2019年 | 612篇 |
2018年 | 597篇 |
2017年 | 522篇 |
2016年 | 539篇 |
2015年 | 462篇 |
2014年 | 820篇 |
2013年 | 1002篇 |
2012年 | 603篇 |
2011年 | 699篇 |
2010年 | 519篇 |
2009年 | 589篇 |
2008年 | 507篇 |
2007年 | 510篇 |
2006年 | 409篇 |
2005年 | 310篇 |
2004年 | 306篇 |
2003年 | 265篇 |
2002年 | 219篇 |
2001年 | 217篇 |
2000年 | 158篇 |
1999年 | 134篇 |
1998年 | 124篇 |
1997年 | 140篇 |
1996年 | 93篇 |
1995年 | 74篇 |
1994年 | 58篇 |
1993年 | 53篇 |
1992年 | 48篇 |
1991年 | 37篇 |
1990年 | 40篇 |
1989年 | 27篇 |
1988年 | 35篇 |
1987年 | 19篇 |
1986年 | 31篇 |
1985年 | 37篇 |
1984年 | 33篇 |
1983年 | 13篇 |
1982年 | 14篇 |
1981年 | 27篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
81.
目的 分析南通市中小学生食源性疾病流行病学特征,为有效防控中小学生食源性疾病提供科学依据。方法 收集2015—2020年南通市哨点医院就诊的中小学生食源性疾病病例信息,并采集病例粪便标本进行病原体检测,运用χ2检验比较不同学段中小学生食源性疾病病例的分布。结果 共监测中小学生食源性疾病病例1 432例。不同可疑暴露食品的分类和进食场所的病例数有统计学差异(χ2= 73.421;χ2 = 66.857,P均<0.001),可疑暴露食品主要为肉与肉制品(28.21%)和水产动物及其制品(17.86%),可疑进食场所主要为家庭(57.60%)和学校食堂(12.69%)。疑似食源性疾病暴发事件主要发生在学校食堂。共采集标本214份,检出病原体22份,总体检出率为10.28%,阳性病原体以诺如病毒(3.74%)和副溶血性弧菌(3.27%)为主。结论 需面向家庭、学校和学生开展有针对性的食品安全知识宣传,加强中小学生食源性疾病的重点食品和场所的食品安全监测和监管,最大限度地减少中小学生食源性疾病的发生。 相似文献
82.
目的 分析徐州市泉山区中小学生因病缺课情况,为制定疾病预防控制措施、降低学生因病缺课率提供依据。方法 收集2016—2020学年泉山区中小学生因病缺课监测数据,分析不同年份学生因病缺课的流行特征,采用χ2检验进行统计比较。结果 2016—2020学年泉山区学生总因病缺课率为0.15%,呈逐年上升趋势(χ2趋势=21 732.656,P<0.001);总因病缺课率小学生(0.16%)高于初中生(0.11%,χ2=1 419.185,P<0.001)、高中生(0.07%,χ2=2 426.638,P<0.001),初中生高于高中生(χ2=491.878,P<0.001);传染性疾病导致的缺课人次数占因病缺课总人次数的66.05%;学生因病缺课高峰主要集中在11月至次年1月。结论 小学生是缺课的重点关注人群,传染病是中小学生疾病防控工作的重点,应采取综合干预措施,降低学生缺课率,保障学生身体健康。 相似文献
83.
Poor health and low cardiorespiratory fitness (CRF) contribute substantially to the shortened lifespan of individuals with schizophrenia spectrum disorders (SSDs). Increasing physical activity has demonstrated value; however, there are limited interventions that are accessible and adequately address motivational challenges. This paper reports on an open trial of Physical Activity Can Enhance Life (PACE-Life), a motivational theory-based manualized multicomponent walking intervention. The primary aim was to examine the feasibility of implementing PACE-Life through meeting the recruitment target (n = 14), attendance and adherence rates, and participant feedback. The secondary aim was to assess the impact of PACE-Life on intermediate targets (autonomous motivation and satisfaction of autonomy, relatedness, and competence needs), proximal outcomes (Fitbit steps/day and minutes spent walking), the primary outcome (CRF), and secondary outcomes (loneliness, symptoms, resting heart rate, blood pressure, weight, body mass index, and hip and waist circumference). Seventeen participants with SSDs enrolled in a 24-week open trial. Assessments occurred at baseline, mid-point, post-test, and one-month follow-up. The recruitment target was exceeded, the group attendance rate was 34%, Fitbit adherence rate was 54%, and participant feedback indicated satisfaction with the intervention as well as a positive group environment. There was a large improvement in the primary outcome of CRF with 77% of participants achieving clinically significant improvement at post-test. Small and medium effect size increases were observed in autonomous motivation and satisfaction of autonomy, relatedness, and competence needs. Fitbit data and secondary outcomes generally remained unchanged or worsened during the intervention. Results from this open trial indicate that PACE-Life leads to meaningful changes in CRF among people with SSDs. 相似文献
84.
Mara L. Leimanis-Laurens Karen Ferguson Emily Wolfrum Brian Boville Dominic Sanfilippo Todd A. Lydic Jeremy W. Prokop Surender Rajasekaran 《Nutrients》2021,13(3)
Lipids are molecules involved in metabolism and inflammation. This study investigates the plasma lipidome for markers of severity and nutritional status in critically ill children. Children with multi-organ dysfunction syndrome (MODS) (n = 24) are analyzed at three time-points and cross-referenced to sedation controls (n = 4) for a total of N = 28. Eight of the patients with MODS, needed veno-arterial extracorporeal membrane oxygenation (VA ECMO) support to survive. Blood plasma lipid profiles are quantified by nano-electrospray (nESI), direct infusion high resolution/accurate mass spectrometry (MS), and tandem mass spectrometry (MS/MS), and compared to nutritional profiles and pediatric logistic organ dysfunction (PELOD) scores. Our results show that PELOD scores were not significantly different between MODS and ECMO cases across time-points (p = 0.66). Lipid profiling provides stratification between sedation controls and all MODS patients for total lysophosphatidylserine (lysoPS) (p-value = 0.004), total phosphatidylserine (PS) (p-value = 0.015), and total ether-linked phosphatidylethanolamine (ether-PE) (p-value = 0.03) after adjusting for sex and age. Nutrition intake over time did not correlate with changes in lipid profiles, as measured by caloric and protein intake. Lipid measurement in the intensive care environment shows dynamic changes over an 8-day pediatric intensive care unit (PICU) course, suggesting novel metabolic indicators for defining critically ill children. 相似文献
85.
杨佳芳胡龙军黄灿灿王金琪夏洪斌周靓甘寅张戟侯冷晨 《中国卫生质量管理》2021,(1):036-38
基于移动管理平台,对传统危急值管理进行改进,使手机移动端具备危急值管理功能,实现在手机移动端查看、提醒和监控危急值。平台应用后,临床科室在5 min内、10 min内、20 min内、30 min内危急值平均处置效率分别为31.43%、58.32%、70.05%、80.76%。运用移动管理平台,可提高对危急值处置和监管的及时性,提升危急值闭环管理能力,进一步保障患者安全。 相似文献
86.
Sarah A. Collier Li Deng Elizabeth A. Adam Katharine M. Benedict Elizabeth M. Beshearse Anna J. Blackstock Beau B. Bruce Gordana Derado Chris Edens Kathleen E. Fullerton Julia W. Gargano Aimee L. Geissler Aron J. Hall Arie H. Havelaar Vincent R. Hill Robert M. Hoekstra Sujan C. Reddy Elaine Scallan Erin K. Stokes Jonathan S. Yoder Michael J. Beach 《Emerging infectious diseases》2021,27(1):140
Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates of the health burden for all water exposure routes (ingestion, contact, inhalation) and sources (drinking, recreational, environmental) are needed. We estimated total illnesses, emergency department (ED) visits, hospitalizations, deaths, and direct healthcare costs for 17 waterborne infectious diseases. About 7.15 million waterborne illnesses occur annually (95% credible interval [CrI] 3.88 million–12.0 million), results in 601,000 ED visits (95% CrI 364,000–866,000), 118,000 hospitalizations (95% CrI 86,800–150,000), and 6,630 deaths (95% CrI 4,520–8,870) and incurring US $3.33 billion (95% CrI 1.37 billion–8.77 billion) in direct healthcare costs. Otitis externa and norovirus infection were the most common illnesses. Most hospitalizations and deaths were caused by biofilm-associated pathogens (nontuberculous mycobacteria, Pseudomonas, Legionella), costing US $2.39 billion annually. 相似文献
87.
《Journal of the American Medical Directors Association》2022,23(12):2015-2022.e5
ObjectivesTo explore formal and informal care costs in the last 3 months of life for people with dementia, and to evaluate the association between transitions to hospital and usual place of care with costs.DesignCross-sectional study using pooled data from 3 mortality follow-back surveys.Setting and ParticipantsPeople who died with dementia.MethodsThe Client Service Receipt Inventory survey was used to derive formal (health, social) and informal care costs in the last 3 months of life. Generalized linear models were used to explore the association between transitions to hospital and usual place of care with formal and informal care costs.ResultsA total of 146 people who died with dementia were included. The mean age was 88.1 years (SD 6.0), and 98 (67.1%) were female. The usual place of care was care home for 85 (58.2%). Sixty-five individuals (44.5%) died in a care home, and 85 (58.2%) experienced a transition to hospital in the last 3 months. The mean total costs of care in the last 3 months of life were £31,224.7 (SD 23,536.6). People with a transition to hospital had higher total costs (£33,239.2, 95% CI 28,301.8-39,037.8) than people without transition (£21,522.0, 95% CI 17,784.0-26,045.8), mainly explained by hospital costs. People whose usual place of care was care homes had lower total costs (£23,801.3, 95% CI 20,172.0-28,083.6) compared to home (£34,331.4, 95% CI 27,824.7-42,359.5), mainly explained by lower informal care costs.Conclusions and ImplicationsTotal care costs are high among people dying with dementia, and informal care costs represent an important component of end-of-life care costs. Transitions to hospital have a large impact on total costs; preventing these transitions might reduce costs from the health care perspective, but not from patients' and families' perspectives. Access to care homes could help reduce transitions to hospital as well as reduce formal and informal care costs. 相似文献
88.
乌拉地尔对重症高血压患者血浆降钙素基因相关肽、内皮素、神经肽Y含量的影响 总被引:4,自引:2,他引:2
目的:观察乌拉地尔(Ura)对重症高血压(CH)患者血浆降钙素基因相关肽(CGRP)、内皮素(ET)、神经肽Y(NPY)含量的影响。方法:用放射免疫分析方法测定30例CH患者血浆CGRP、ET、NPY水平,并以40例健康者作对照。观察CH患者静脉注射Ura(0.4-0.6mg/kg)后诸指标变化。结果:CH患者血浆CGRP水平显著低于健康对照组(P<0.01),ET和NPY明显高于健康对照组(均P<0.01)。经Ura治疗后CH患者CGRP水平明显升高,ET、NPY水平明显下降(均P<0.01)。结论:CGRP,ET和NPY是参与CH发病的重要体液因素,Ura可明显提高CH患者体内CGRP水平,有效拮抗ET和NPY的缩血管作用,对改善CH患者血流动力学和心肌氧供需失平衡有重要作用。 相似文献
89.
90.
M. Gasparini S. Khan J. M. Patel D. Parekh M. N. Bangash R. Stϋmpfle A. Shah B. Baharlo S. Soni Collaborators 《Anaesthesia》2021,76(3):320-326
Renal impairment is common in patients who are critically ill with coronavirus disease-19 (COVID-19). We examined the association between acute and chronic kidney disease with clinical outcomes in 372 patients with coronavirus disease-19 admitted to four regional intensive care units between 10 March 2020 and 31 July 2020. A total of 216 (58%) patients presented with COVID-19 and renal impairment. Acute kidney injury and/or chronic kidney disease was associated with greater in-hospital mortality compared with patients with preserved renal function (107/216 patients (50%) (95%CI 44–57) vs. 32/156 (21%) (95%CI 15–28), respectively; p < 0.001, relative risk 2.4 (95%CI 1.7–3.4)). Mortality was greatest in patients with renal transplants (6/7 patients (86%) (95%CI 47–100)). Mortality rates increased in patients with worsening renal injury according to the Kidney Disease: Improving Global Outcomes classification: stage 0 mortality 33/157 patients (21%) (95%CI 15–28) vs. stages 1–3 mortality 91/186 patients (49%) (95%CI 42–56); p < 0.001, relative risk 2.3 (95%CI 1.7–3.3). Survivors were less likely to require renal replacement therapy compared with non-survivors (57/233 patients (24%) vs. 64/139 patients (46%), respectively; p < 0.001, relative risk 1.9 (95%CI 1.4–2.5)). One-fifth of survivors who required renal replacement therapy acutely in intensive care continued to require renal support following discharge. Our data demonstrate that renal impairment in patients admitted to intensive care with COVID-19 is common and is associated with a high mortality and requirement for on-going renal support after discharge from critical care. Our findings have important implications for future pandemic planning in this patient cohort. 相似文献